ConductCognition

  • Domains

    Tests

    • Processing speed43
    • Attention113
    • Working memory50
    • Executive function143
    • Episodic memory72
    • Response inhibition9
    • Social cognition75
    • Language42

    Most used

    Evidence

    1. Verbal Fluency TestGradeA
    2. Stroop Color-Word TestGradeA
    3. Trail Making TestGradeA
    4. N-Back TaskGradeA
    5. Go/No-Go TaskGradeA
    6. Digit Span TestGradeA
    7. Symbol Coding TestGradeA
    8. Verbal Learning TestGradeA
    REDTry it nowStroop Color-Word Test
    All 547 tests

    Browse by

    • Phone290
    • Tablet323
    • Untimed326
    • Up to 5 minutes69
    • Evidence grade A40

  • First studies

    Grade, length

    • Reaction Time StudyGradeA7 min
    • Pilot ScreeningGradeA15 min
    • Medication StudiesGradeA−26 min
    • Language-Minimized ScreeningGradeA−30 min

    Age groups

    • Older Adult Executive SpeedGradeA20 min
    • School-AgeGradeA−33 min

    Memory

    • At-Home MemoryGradeA26 min
    • Working Memory and LearningGradeA−19 min
    • Associative MemoryGradeB32 min
    • Working Memory CapacityGradeB34 min

    Language and perception

    • LanguageGradeA−33 min
    • Visual PerceptionGradeB27 min
    • Listening and Auditory ProcessingGradeB31 min

    Executive function and attention

    • Executive ControlGradeA18 min
    • Attention and ImpulsivityGradeA−26 min
    • Visual AttentionGradeB27 min
    • Creativity and Flexible ThinkingGradeB30 min
    • Reasoning and SpatialGradeB32 min

    Movement

    • Motor and AttentionGradeA−29 min
    • Motor LearningGradeB34 min

    Behavior, mood and choice

    • Food Choice and Self-ControlGradeA−29 min
    • Sleep and FatigueGradeB23 min
    • Social CognitionGradeB23 min
    • Impulsivity and Substance UseGradeB26 min
    • Emotion and MoodGradeB28 min
    • Decisions and RewardGradeB29 min
    All 26 batteries

    Find one

    Up to 15 minutes2Up to 30 minutes19Phone8
    Test order labBattery gradesHow batteries work

  • Use and evidence

    • Overview
    • Compare all 547 tests
    • Test-retest
    • Reliability and validity
    • Battery grades26
    • Download and cite

    Clinical trials

    • Overview
    • By condition25
    • By test101
    • Trial design benchmark
    • Cognitive outcomes, 2026

    Conditions

    Registered studies

    • Dementia and Alzheimer's1,673
    • Aging, frailty and exercise1,398
    • Depression and bipolar disorder1,247
    • Stroke1,233
    • Substance use and addiction895
    • Parkinson's disease892
    • Cancer760
    All 25 conditions
    16,361Registered studies name a cognitive test in an outcome measure11,688 name a test you can run hereExplore the studies
  • 1

    Build

    • Study design
    • Customize tests
    • Repeat visits
    • Study cost calculator
    2

    Recruit

    • Recruitment setup
    • Prolific
    • Sona Systems
    • CloudResearch Connect
    • Qualtrics
    3

    Run

    • Remote testing
    • Participant devices
    • Phone timing check
    • Offline edition
    4

    Results

    • Automated scoring
    • Test norms
    • Study Quality Monitor
    • Data export
    Platform overview

    Compliance

    • HIPAA-ready testing
    • US clinical research
    • Data Policy
    • Privacy Policy
    • Terms of Use

  • Research areas

    Tests used in each

    • Aging and dementia188
    • Decisions and reward105
    • Child development and education87
    • Language and bilingualism64
    • Social behavior62
    • Psychiatric groups35
    • Training and intervention28
    • Mood, anxiety and trauma25
    • Substance use and impulsivity25
    • Neurological and movement research19
    • Brain injury and concussion14
    • Sleep and fatigue14
    • ADHD11
    • Eating and obesity8
    • Medication and drug trials8

    Research settings

    • Student participant pools
    • Teaching a class
    • Clinical trials
    • US clinical research
    • Sites without internet
    Planning a study?

  • Methods

    • How evidence grades work
    • How test batteries work
    • How test order works
    Methods and questions

    Help

    • FAQ
    • Recruitment guides
    • Compare platforms

    Updates

    • Blog
    • New tests by email
    Latest post10 November 2026What you can do in ConductCognition todayA short tour of ConductCognition as it stands on 10 November. After this, we'll post when something changes how you run a study.Read the post
  • Pricing
Start Free
Log In
Log InStart Free
  1. Home
  2. /Data
  3. /Clinical trials
  4. /Tests
  5. /Antisaccade Task

Clinical trials data

Antisaccade Task in clinical trials: 68 registered studies

Every registered study on ClinicalTrials.gov that names the Antisaccade Task in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.

Registered studies name it in an outcome measure
68
Name it in a primary outcome, 60%
41 of 68
Against similar tests
Of studies started 2021 to 2025 name it, against 0.5% in 2016 to 2020
0.3%
By year
Median participants per study
80
By phase
Try the Antisaccade Task

The conditions it is used in

Each study counted once in each condition group it falls in.

  1. Healthy volunteers12 studies, 12 as a primary outcome

  2. Substance use and addiction7 studies, 4 as a primary outcome

  3. Depression and bipolar disorder6 studies, 4 as a primary outcome

  4. Schizophrenia and psychosis5 studies, 5 as a primary outcome

  5. Dementia and Alzheimer's4 studies, 3 as a primary outcome

  6. Stroke3 studies, 1 as a primary outcome

  7. Parkinson's disease3 studies, 2 as a primary outcome

  8. Aging, frailty and exercise3 studies, 0 as a primary outcome

  9. Anxiety, PTSD and OCD3 studies, 0 as a primary outcome

  10. Mild cognitive impairment2 studies, 0 as a primary outcome

  11. Brain injury and concussion2 studies, 2 as a primary outcome

  12. Multiple sclerosis2 studies, 1 as a primary outcome

  13. ADHD2 studies, 1 as a primary outcome

  14. Obesity and diabetes2 studies, 0 as a primary outcome

  15. Autism2 studies, 2 as a primary outcome

  16. Sleep and sleep disorders2 studies, 0 as a primary outcome

  17. Cancer1 study, 1 as a primary outcome

  18. Cognitive impairment and decline1 study, 0 as a primary outcome

  19. Other conditions15 studies, 8 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

The Antisaccade Task is a primary outcome in 60% of its studies. Across the 4 response inhibition tests with a page here, the median is 45%.

  1. Antisaccade Task60% of 68 studies

  2. Stop-Signal Task46% of 321 studies

  3. Go/No-Go Task44% of 702 studies

  4. Affective Go/No-Go38% of 48 studies

Studies by start year

0.3% of the registered studies that started in 2021 to 2025 name it, against 0.5% of those that started in 2016 to 2020. 2026 is partly planned starts.
02000: 0 studies, 0 with a test as a primary outcome20002001: 0 studies, 0 with a test as a primary outcome2002: 0 studies, 0 with a test as a primary outcome2003: 1 studies, 1 with a test as a primary outcome2004: 0 studies, 0 with a test as a primary outcome2005: 0 studies, 0 with a test as a primary outcome20052006: 0 studies, 0 with a test as a primary outcome2007: 1 studies, 1 with a test as a primary outcome2008: 2 studies, 1 with a test as a primary outcome2009: 0 studies, 0 with a test as a primary outcome2010: 2 studies, 2 with a test as a primary outcome20102011: 0 studies, 0 with a test as a primary outcome2012: 0 studies, 0 with a test as a primary outcome2013: 2 studies, 2 with a test as a primary outcome2014: 4 studies, 2 with a test as a primary outcome2015: 3 studies, 2 with a test as a primary outcome20152016: 3 studies, 2 with a test as a primary outcome2017: 5 studies, 4 with a test as a primary outcome2018: 5 studies, 4 with a test as a primary outcome2019: 3 studies, 2 with a test as a primary outcome2020: 5 studies, 4 with a test as a primary outcome20202021: 1 studies, 0 with a test as a primary outcome2022: 5 studies, 1 with a test as a primary outcome2023: 7 studies, 3 with a test as a primary outcome2024: 6 studies, 3 with a test as a primary outcome2025: 3 studies, 2 with a test as a primary outcome20252026: 10 studies, 5 with a test as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table
Registered studies by start year
Start yearStudiesA test as a primary outcome
200000
200100
200200
200311
200400
200500
200600
200711
200821
200900
201022
201100
201200
201322
201442
201532
201632
201754
201854
201932
202054
202110
202251
202373
202463
202532
2026105

Phases and study sizes

By phase

  • Early phase 11 studies, 1 as a primary outcome
  • Phase 12 studies, 0 as a primary outcome
  • Phase 25 studies, 3 as a primary outcome
  • Phase 42 studies, 2 as a primary outcome
  • Not applicable49 studies, 30 as a primary outcome
  • Observational9 studies, 5 as a primary outcome

Participants per study

102050100
  • Not applicable80 median, 36 to 120
Participants per study. The bar spans the middle half of the studies in each phase, the mark is the median, and the axis is logarithmic. Phases with fewer than 10 studies that give a size are left out.
Show as a table
Participants per study that names the Antisaccade Task, by phase
PhaseStudies with a sizeMedianMiddle half
Not applicable488036 to 120

When trials measure it

Half of the primary outcomes that name the Antisaccade Task are measured within a day of the start, and the middle half from the first day to 4 weeks. 36 primary outcomes give a duration.

Latest time point of each outcome

  • Within a day25 outcomes, 20 as a primary outcome
  • Up to 4 weeks13 outcomes, 8 as a primary outcome
  • 1 to 3 months10 outcomes, 4 as a primary outcome
  • 3 to 6 months7 outcomes, 2 as a primary outcome
  • 6 to 12 months4 outcomes, 1 as a primary outcome
  • 1 to 2 years1 outcomes, 0 as a primary outcome
  • Over 2 years1 outcomes, 1 as a primary outcome
  • No duration given7 outcomes, 5 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

61 of the 68 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

  • Recruiting12 studies, 6 as a primary outcome
  • Not yet recruiting6 studies, 2 as a primary outcome
  • Active, not recruiting1 studies, 0 as a primary outcome
  • Completed34 studies, 21 as a primary outcome
  • Stopped early2 studies, 1 as a primary outcome
  • Status unknown13 studies, 11 as a primary outcome

What they test

  • Behavioral15 studies, 8 as a primary outcome
  • Drug22 studies, 17 as a primary outcome
  • Device15 studies, 9 as a primary outcome
  • Dietary supplement2 studies, 1 as a primary outcome
  • Procedure2 studies, 2 as a primary outcome
  • Biological1 studies, 0 as a primary outcome
  • Other15 studies, 7 as a primary outcome
  • None given5 studies, 2 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

Where their sites are

  • United States21 studies, 14 as a primary outcome
  • China19 studies, 13 as a primary outcome
  • Canada6 studies, 3 as a primary outcome
  • United Kingdom6 studies, 3 as a primary outcome
  • France4 studies, 3 as a primary outcome
  • Germany2 studies, 0 as a primary outcome
  • Hong Kong2 studies, 2 as a primary outcome
  • Switzerland2 studies, 1 as a primary outcome
  • Brazil1 studies, 0 as a primary outcome
  • Israel1 studies, 0 as a primary outcome
  • Norway1 studies, 1 as a primary outcome
  • Palestinian Territories1 studies, 0 as a primary outcome

13 countries in all. A study with sites in several counts in each; 4 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name the Antisaccade Task: 12 of 34, 35%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name the Antisaccade Task and every completed study, by how they reported results
ResultsCompleted studies that name the Antisaccade TaskEvery completed study
Results on ClinicalTrials.gov and a paper2, 6%776, 10%
Results on ClinicalTrials.gov only4, 12%1,139, 14%
A results paper only6, 18%1,711, 22%
Neither22, 65%4,327, 54%

Tests named in the same studies

The library tests that studies naming the Antisaccade Task name most often beside it.
  1. 1

    N-Back Task7 studies, 3 as a primary outcome

  2. 2

    Continuous Performance Test6 studies, 5 as a primary outcome

  3. 3

    Go/No-Go Task6 studies, 3 as a primary outcome

  4. 4

    Eriksen Flanker Task4 studies, 2 as a primary outcome

  5. 5

    Verbal Fluency4 studies, 2 as a primary outcome

  6. 6

    Verbal Learning4 studies, 2 as a primary outcome

  7. 7

    Stop-Signal Task4 studies, 1 as a primary outcome

  8. 8

    Category Fluency3 studies, 2 as a primary outcome

  9. 9

    Trail Making Test3 studies, 2 as a primary outcome

  10. 10

    Effort Discounting Task2 studies, 2 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for the Antisaccade Task and the tests named with it most. Add or remove tests to compare.
Antisaccade Task68 studies, 2000 to 2026
0501002000201020202026
N-Back Task787 studies, 2000 to 2026
0501002000201020202026
Continuous Performance Test632 studies, 2000 to 2026
0501002000201020202026
Go/No-Go Task699 studies, 2000 to 2026
0501002000201020202026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table
Registered studies per start year that name each test
Start yearAntisaccade TaskN-Back TaskContinuous Performance TestGo/No-Go Task
20000010
20010011
20020232
20031261
20040062
20050480
20060381
2007110111
2008210104
200905165
2010211148
20110202013
20120141713
20132232019
20144252722
20153252424
20163323234
20175513737
20185543740
20193594146
20205302932
20211703962
20225623660
20237716567
20246695364
20253674177
202610683064

Explore the 68 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.
TestThe Antisaccade Task

68 studies match. 41 name the Antisaccade Task in a primary outcome. Median size 80 participants. Median time to the primary outcome: same day.

Loading 68 studies; the filters turn on when they arrive.

By start year
02.557.5102000: 0 studies, 0 naming the Antisaccade Task in a primary outcome20002001: 0 studies, 0 naming the Antisaccade Task in a primary outcome2002: 0 studies, 0 naming the Antisaccade Task in a primary outcome2003: 1 studies, 1 naming the Antisaccade Task in a primary outcome2004: 0 studies, 0 naming the Antisaccade Task in a primary outcome2005: 0 studies, 0 naming the Antisaccade Task in a primary outcome20052006: 0 studies, 0 naming the Antisaccade Task in a primary outcome2007: 1 studies, 1 naming the Antisaccade Task in a primary outcome2008: 2 studies, 1 naming the Antisaccade Task in a primary outcome2009: 0 studies, 0 naming the Antisaccade Task in a primary outcome2010: 2 studies, 2 naming the Antisaccade Task in a primary outcome20102011: 0 studies, 0 naming the Antisaccade Task in a primary outcome2012: 0 studies, 0 naming the Antisaccade Task in a primary outcome2013: 2 studies, 2 naming the Antisaccade Task in a primary outcome2014: 4 studies, 2 naming the Antisaccade Task in a primary outcome2015: 3 studies, 2 naming the Antisaccade Task in a primary outcome20152016: 3 studies, 2 naming the Antisaccade Task in a primary outcome2017: 5 studies, 4 naming the Antisaccade Task in a primary outcome2018: 5 studies, 4 naming the Antisaccade Task in a primary outcome2019: 3 studies, 2 naming the Antisaccade Task in a primary outcome2020: 5 studies, 4 naming the Antisaccade Task in a primary outcome20202021: 1 studies, 0 naming the Antisaccade Task in a primary outcome2022: 5 studies, 1 naming the Antisaccade Task in a primary outcome2023: 7 studies, 3 naming the Antisaccade Task in a primary outcome2024: 6 studies, 3 naming the Antisaccade Task in a primary outcome2025: 3 studies, 2 naming the Antisaccade Task in a primary outcome20252026: 10 studies, 5 naming the Antisaccade Task in a primary outcome

2026 is partly planned starts.

Show as a table
Matching studies by start year
Start yearStudiesAs a primary outcome
200000
200100
200200
200311
200400
200500
200600
200711
200821
200900
201022
201100
201200
201322
201442
201532
201632
201754
201854
201932
202054
202110
202251
202373
202463
202532
2026105

Library tests named most

  • Antisaccade Task68 studies, 41 as a primary outcome
  • N-Back Task7 studies, 3 as a primary outcome
  • Continuous Performance Test6 studies, 5 as a primary outcome
  • Go/No-Go Task6 studies, 3 as a primary outcome
  • Eriksen Flanker Task4 studies, 2 as a primary outcome
  • Verbal Fluency4 studies, 2 as a primary outcome
  • Verbal Learning4 studies, 2 as a primary outcome
  • Stop-Signal Task4 studies, 1 as a primary outcome
  • Category Fluency3 studies, 2 as a primary outcome
  • Trail Making Test3 studies, 2 as a primary outcome

Largest condition groups

Phases

Participants

Lead sponsor: industry 3, other 65. Interventional 59, observational 9.

As a primary outcomeSecondary or other outcomeThe Antisaccade Task

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
StudyStartPhaseConditionsParticipantsLead sponsorStatusLibrary tests named, with the latest time point
NCT07886450Start2026PhaseObservationalConditionsParkinson's diseaseParticipants128Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Antisaccade TaskPrimarysame day
NCT07798349Start2026PhaseNot applicableConditionsHealthy volunteersParticipants120Lead sponsorOtherStatusRecruitingLibrary tests named
  • Antisaccade TaskPrimary1 week
NCT07702526Start2026PhaseNot applicableConditionsSchizophrenia and psychosisParticipants160Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Trail Making TestPrimary4 weeks
  • Verbal LearningPrimary4 weeks
  • Continuous Performance TestPrimary4 weeks
  • Category FluencyPrimary4 weeks
  • Antisaccade TaskPrimary4 weeks
NCT07604246Start2026PhaseNot applicableConditionsCancer, Substance use and addictionParticipants25Lead sponsorOtherStatusRecruitingLibrary tests named
  • Antisaccade TaskPrimarysame day
NCT07530731Start2026PhaseNot applicableConditionsOther conditionsParticipants36Lead sponsorIndustryStatusCompletedLibrary tests named
  • Antisaccade TaskPrimary
NCT07499167Start2026PhaseNot applicableConditionsOther conditionsParticipants10Lead sponsorOtherStatusActive, not recruitingLibrary tests named
  • Antisaccade TaskSecondarysame day
  • Posner CueingSecondarysame day
NCT07448675Start2023PhaseObservationalConditionsCognitive impairment and declineParticipants230Lead sponsorOtherStatusRecruitingLibrary tests named
  • Oddball Target DetectionSecondary12 weeks
  • Antisaccade TaskSecondary12 weeks
NCT07254949Start2026PhaseObservationalConditionsStrokeParticipants425Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Antisaccade TaskOther outcome6 months
NCT07140237Start2025PhaseEarly phase 1ConditionsHealthy volunteersParticipants250Lead sponsorOtherStatusRecruitingLibrary tests named
  • Antisaccade TaskPrimarysame day
NCT06826326Start2025PhasePhase 2ConditionsAutismParticipants5Lead sponsorOtherStatusRecruitingLibrary tests named
  • Antisaccade TaskPrimary4 weeks
NCT06825962Start2025PhaseNot applicableConditionsOther conditionsParticipants16Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • N-Back TaskOther outcomesame day
  • Go/No-Go TaskOther outcomesame day
  • Antisaccade TaskOther outcomesame day
NCT06763692Start2026PhaseNot applicableConditionsParkinson's diseaseParticipants15Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Antisaccade TaskSecondary13 weeks
NCT06733714Start2024PhaseNot applicableConditionsDementia and Alzheimer's, Mild cognitive impairmentParticipants40Lead sponsorOtherStatusRecruitingLibrary tests named
  • Verbal LearningSecondary1 week
  • Verbal FluencySecondary1 week
  • Category FluencySecondary1 week
  • Complex Figure Copy and RecallSecondary1 week
  • Oddball Target DetectionSecondary1 week
  • Antisaccade TaskSecondary1 week
  • Visual Search TestSecondary1 week
NCT06691646Start2018PhaseNot applicableConditionsADHDParticipants35Lead sponsorOtherStatusCompletedLibrary tests named
  • Antisaccade TaskPrimary2 weeks
NCT06659094Start2023PhaseNot applicableConditionsAnxiety, PTSD and OCDParticipants95Lead sponsorOtherStatusCompletedLibrary tests named
  • Antisaccade TaskOther outcome6 weeks
NCT06600438Start2026PhaseNot applicableConditionsOther conditionsParticipants110Lead sponsorOtherStatusRecruitingLibrary tests named
  • Finger Tapping TaskSecondary18 months
  • Antisaccade TaskSecondary18 months
NCT06441552Start2024PhaseObservationalConditionsStrokeParticipants200Lead sponsorOtherStatusRecruitingLibrary tests named
  • Cancellation TestSecondary3 weeks
  • Antisaccade TaskSecondary12 months
NCT06351540Start2026PhasePhase 1ConditionsSubstance use and addictionParticipants40Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Continuous Performance TestPrimarysame day
  • Antisaccade TaskSecondarysame day
NCT06344559Start2024PhaseNot applicableConditionsHealthy volunteersParticipants60Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Antisaccade TaskPrimarysame day
  • Effort Discounting TaskPrimarysame day
NCT06329050Start2024PhaseNot applicableConditionsHealthy volunteersParticipants80Lead sponsorOtherStatusStatus unknown

Paper

Library tests named
  • Antisaccade TaskPrimarysame day
NCT06329037Start2024PhaseNot applicableConditionsHealthy volunteersParticipants80Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Antisaccade TaskPrimarysame day
NCT06243016Start2024PhaseNot applicableConditionsAging, frailty and exerciseParticipants54Lead sponsorOtherStatusRecruitingLibrary tests named
  • Eriksen Flanker TaskSecondarysame day
  • Antisaccade TaskSecondary
NCT06181747Start2023PhaseNot applicableConditionsADHDParticipants110Lead sponsorOtherStatusCompleted

Paper

Library tests named
  • Continuous Performance TestPrimary4 weeks
  • Antisaccade TaskSecondary4 weeks
NCT05945342Start2023PhaseNot applicableConditionsDepression and bipolar disorderParticipants100Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Iowa Gambling LitePrimary8 weeks
  • Antisaccade TaskPrimary6 months
NCT05776511Start2023PhaseNot applicableConditionsMultiple sclerosisParticipants150Lead sponsorOtherStatusRecruitingLibrary tests named
  • Antisaccade TaskPrimary

Page 1 of 3

Questions, answered from the data

How many clinical trials use the Antisaccade Task?

68 registered studies on ClinicalTrials.gov name it in an outcome measure, 41 of them in a primary outcome.

In which conditions do trials use the Antisaccade Task?

Most often in healthy volunteers (12), substance use and addiction (7) and depression and bipolar disorder (6).

Do new trials use the Antisaccade Task more or less?

0.3% of the studies that started in 2021 to 2025 name it, against 0.5% of those that started in 2016 to 2020: a share 34% smaller.

Which tests do trials use with the Antisaccade Task?

The N-Back Task (7 studies), the Continuous Performance Test (6 studies) and the Go/No-Go Task (6 studies).

When do trials measure the Antisaccade Task?

Half of the primary outcomes that name the Antisaccade Task are measured within a day of the start, and the middle half from the first day to 4 weeks. 36 primary outcomes give a duration.

How many completed trials that use the Antisaccade Task have reported results?

12 of the 34 completed studies that name it, 35%, have reported results: 6 posted them on ClinicalTrials.gov, 8 have a results paper linked to the registry record, and 2 did both. The other 22 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.

More on tests in clinical trials

  • Antisaccade Task: what it measures, its scores, and a version to try
  • All 101 tests in clinical trials
  • Cognitive tests by condition
  • Every registered study, by test, condition, phase and year

How the studies are counted

For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.

The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.

A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.

A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.

Run the Antisaccade Task in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free
ConductCognition

Hosted browser-native cognitive testing for academic and commercial research workflows.

A product of ConductScience, Inc.

New tests and features, about once a month. Unsubscribe at any time.

Tests

  • All cognitive tests
  • Test batteries
  • Use and evidence
  • Test norms
  • Trail Making Test
  • N-Back Task
  • Automated scoring
  • Study design
  • New tests by email

Guides

  • Methods and questions
  • Blog
  • Recruitment setup
  • Participant devices
  • Prolific
  • Sona Systems
  • CloudResearch Connect
  • Qualtrics

Use cases

  • Student participant pools
  • Aging and dementia research
  • Clinical trials
  • US clinical research
  • Remote testing

Compare and buy

  • Pricing
  • Compare platforms
  • Offline edition
  • FAQ

Trust

  • Study Quality Monitor
  • HIPAA-ready testing
  • Data export
  • Privacy Policy
  • Terms of Use
  • Data Policy

Company

  • ConductScience
  • Affiliate Program
© 2026 ConductScience, Inc. Research use only.